Deferasorox

Novadoz Pharmaceuticals LLC🇺🇸 United States

FDA Page

Effective Date: May 20, 2022
Approval ID: 1122f1c0-c160-49db-a31b-90d7521370f5
Products: 3 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DEFERASIROX ORAL GRANULES safely and effectively. See full prescribing information for DEFERASIROX ORAL GRANULES. DEFERASIROX oral granules, for oral use Initial U.S. Approval: 2005

Quick Stats

Total Products3

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.